Regulated Electric
Build Your Comparison
Side-by-side financial analysisStock Comparison
IMSR vs XOM vs JPM vs BAC vs CVX
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Banks - Diversified
Banks - Diversified
Oil & Gas Integrated
IMSR vs XOM vs JPM vs BAC vs CVX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Regulated Electric | Oil & Gas Integrated | Banks - Diversified | Banks - Diversified | Oil & Gas Integrated |
| Market Cap | $625M | $597.52B | $892.31B | $421.65B | $359.97B |
| Revenue (TTM) | $0.00 | $323.90B | $280.33B | $191.57B | $184.43B |
| Net Income (TTM) | $-46M | $28.84B | $57.05B | $30.51B | $12.30B |
| Gross Margin | — | 21.7% | 60.0% | 56.1% | 30.4% |
| Operating Margin | — | 10.5% | 25.9% | 19.7% | 9.0% |
| Forward P/E | — | 12.9x | 14.3x | 12.5x | 12.6x |
| Total Debt | $2M | $43.54B | $942.38B | $365.90B | $46.74B |
| Cash & Equiv. | $97M | $10.68B | $343.34B | $231.84B | $6.47B |
IMSR vs XOM vs JPM vs BAC vs CVX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Exxon Mobil Corpora… (XOM) | 100 | 315.3 | +215.3% |
| JPMorgan Chase & Co. (JPM) | 100 | 339.6 | +239.6% |
| Bank of America Cor… (BAC) | 100 | 235.2 | +135.2% |
| Chevron Corporation (CVX) | 100 | 202.2 | +102.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IMSR vs XOM vs JPM vs BAC vs CVX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IMSR is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 4.60, Low D/E 0.7%, current ratio 50.62x
XOM is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.
- +29.0% vs IMSR's -66.7%
- 6.4% ROA vs IMSR's -21.0%, ROIC 8.6% vs -18.8%
JPM carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.3%, EPS growth 1.5%
- 475.6% 10Y total return vs XOM's 95.6%
- PEG 0.81 vs BAC's 0.82
- NIM 2.2% vs BAC's 1.8%
BAC ranks third and is worth considering specifically for defensive.
- Beta 0.86, yield 2.3%, current ratio 0.42x
- Beta 0.86 vs IMSR's 4.60
CVX is the clearest fit if your priority is income & stability.
- Dividend streak 38 yrs, beta -0.31, yield 3.8%
- 3.8% yield, 38-year raise streak, vs XOM's 2.8%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.3% NII/revenue growth vs IMSR's -100.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.4% margin vs IMSR's -1.0% | |
| Stability / Safety | Beta 0.86 vs IMSR's 4.60 | |
| Dividends | 3.8% yield, 38-year raise streak, vs XOM's 2.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +29.0% vs IMSR's -66.7% | |
| Efficiency (ROA) | 6.4% ROA vs IMSR's -21.0%, ROIC 8.6% vs -18.8% |
IMSR vs XOM vs JPM vs BAC vs CVX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IMSR vs XOM vs JPM vs BAC vs CVX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
XOM leads 1 • IMSR leads 0 • BAC leads 0 • CVX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM and IMSR operate at a comparable scale, with $323.9B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CVX's 6.7%. On growth, XOM holds the edge at -1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $323.9B | $280.3B | $191.6B | $184.4B |
| EBITDAEarnings before interest/tax | -$38M | $59.9B | $81.4B | $40.0B | $37.1B |
| Net IncomeAfter-tax profit | -$46M | $28.8B | $57.0B | $30.5B | $12.3B |
| Free Cash FlowCash after capex | -$242M | $23.6B | $100.9B | $12.6B | $16.2B |
| Gross MarginGross profit ÷ Revenue | — | +21.7% | +60.0% | +56.1% | +30.4% |
| Operating MarginEBIT ÷ Revenue | — | +10.5% | +25.9% | +19.7% | +9.0% |
| Net MarginNet income ÷ Revenue | — | +8.9% | +20.4% | +15.9% | +6.7% |
| FCF MarginFCF ÷ Revenue | — | +7.3% | +36.0% | +6.6% | +8.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -1.3% | — | — | -5.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -60.3% | -11.0% | +16.0% | +18.3% | -24.5% |
Valuation Metrics
Evenly matched — XOM and JPM and BAC each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 14.6x trailing earnings, BAC trades at a 46% valuation discount to CVX's 27.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs BAC's 0.95x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $625M | $597.5B | $892.3B | $421.6B | $360.0B |
| Enterprise ValueMkt cap + debt − cash | $530M | $630.4B | $1.49T | $555.7B | $400.2B |
| Trailing P/EPrice ÷ TTM EPS | -19.38x | 21.04x | 15.93x | 14.63x | 27.21x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.86x | 14.34x | 12.52x | 12.61x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x | 0.95x | — |
| EV / EBITDAEnterprise value multiple | — | 10.52x | 18.32x | 13.89x | 10.78x |
| Price / SalesMarket cap ÷ Revenue | — | 1.84x | 3.19x | 2.20x | 1.95x |
| Price / BookPrice ÷ Book value/share | 1.83x | 2.28x | 2.46x | 1.39x | 1.74x |
| Price / FCFMarket cap ÷ FCF | — | 25.31x | 8.85x | 33.43x | 21.70x |
Profitability & Efficiency
XOM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-23 for IMSR. IMSR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs XOM's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -23.4% | +10.7% | +15.9% | +10.1% | +7.2% |
| ROA (TTM)Return on assets | -21.0% | +6.4% | +1.3% | +0.9% | +4.2% |
| ROICReturn on invested capital | -18.8% | +8.6% | +4.5% | +3.5% | +6.2% |
| ROCEReturn on capital employed | -16.7% | +8.9% | +8.9% | +4.5% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 5 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 0.16x | 2.60x | 1.21x | 0.24x |
| Net DebtTotal debt minus cash | -$95M | $32.9B | $599.0B | $134.1B | $40.3B |
| Cash & Equiv.Liquid assets | $97M | $10.7B | $343.3B | $231.8B | $6.5B |
| Total DebtShort + long-term debt | $2M | $43.5B | $942.4B | $365.9B | $46.7B |
| Interest CoverageEBIT ÷ Interest expense | -5.45x | 69.44x | 0.74x | 0.48x | 17.22x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $24,852 today (with dividends reinvested), compared to $3,332 for IMSR. Over the past 12 months, XOM leads with a +29.0% total return vs IMSR's -66.7%. The 3-year compound annual growth rate (CAGR) favors JPM at 32.7% vs IMSR's -30.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.8% | +16.6% | -0.9% | +0.9% | +18.0% |
| 1-Year ReturnPast 12 months | -66.7% | +29.0% | +20.3% | +28.3% | +28.3% |
| 3-Year ReturnCumulative with dividends | -66.7% | +44.3% | +133.8% | +100.9% | +26.6% |
| 5-Year ReturnCumulative with dividends | -66.7% | +148.5% | +120.7% | +46.7% | +91.9% |
| 10-Year ReturnCumulative with dividends | -66.7% | +95.6% | +475.6% | +376.2% | +133.7% |
| CAGR (3Y)Annualised 3-year return | -30.7% | +13.0% | +32.7% | +26.2% | +8.2% |
Risk & Volatility
Evenly matched — XOM and BAC each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.37 beta — it tends to amplify market swings less than IMSR's 4.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 97.1% from its 52-week high vs IMSR's 27.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.60x | -0.37x | 0.94x | 0.86x | -0.31x |
| 52-Week HighHighest price in past year | $27.16 | $176.41 | $337.25 | $57.55 | $214.71 |
| 52-Week LowLowest price in past year | $5.33 | $105.53 | $266.85 | $44.06 | $142.40 |
| % of 52W HighCurrent price vs 52-week peak | +27.8% | +79.9% | +94.7% | +97.1% | +84.0% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 43.3 | 65.0 | 71.7 | 48.7 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 13.7M | 7.0M | 31.6M | 8.1M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: XOM as "Hold", JPM as "Buy", BAC as "Buy", CVX as "Buy". Consensus price targets imply 78.6% upside for IMSR (target: $14) vs 6.4% for JPM (target: $340). For income investors, CVX offers the higher dividend yield at 3.81% vs JPM's 1.86%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $13.50 | $170.08 | $339.75 | $61.13 | $200.13 |
| # AnalystsCovering analysts | — | 55 | 61 | 54 | 53 |
| Dividend YieldAnnual dividend ÷ price | — | +2.8% | +1.9% | +2.3% | +3.8% |
| Dividend StreakConsecutive years of raises | — | 43 | 15 | 12 | 38 |
| Dividend / ShareAnnual DPS | — | $4.00 | $5.95 | $1.27 | $6.87 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.4% | +3.9% | +5.1% | +3.3% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). XOM leads in 1 (Profitability & Efficiency). 3 tied.
IMSR vs XOM vs JPM vs BAC vs CVX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IMSR or XOM or JPM or BAC or CVX a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -100. 0% for Terrestrial Energy Inc. (IMSR). Bank of America Corporation (BAC) offers the better valuation at 14. 6x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IMSR or XOM or JPM or BAC or CVX?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
6x versus Chevron Corporation at 27. 2x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Bank of America Corporation's 0. 82x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IMSR or XOM or JPM or BAC or CVX?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +148.
5%, compared to -66. 7% for Terrestrial Energy Inc. (IMSR). Over 10 years, the gap is even starker: JPM returned +475. 6% versus IMSR's -66. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IMSR or XOM or JPM or BAC or CVX?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
37β versus Terrestrial Energy Inc. 's 4. 60β — meaning IMSR is approximately -1333% more volatile than XOM relative to the S&P 500. On balance sheet safety, Terrestrial Energy Inc. (IMSR) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — IMSR or XOM or JPM or BAC or CVX?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -100. 0% for Terrestrial Energy Inc. (IMSR). On earnings-per-share growth, the picture is similar: Bank of America Corporation grew EPS 18. 6% year-over-year, compared to -200. 0% for Terrestrial Energy Inc.. Over a 3-year CAGR, XOM leads at -6. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IMSR or XOM or JPM or BAC or CVX?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 0. 0% for Terrestrial Energy Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 0. 0% for IMSR. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IMSR or XOM or JPM or BAC or CVX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Bank of America Corporation's 0. 82x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 5x forward P/E versus 14. 3x for JPMorgan Chase & Co. — 1. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IMSR: 78. 6% to $13. 50.
08Which pays a better dividend — IMSR or XOM or JPM or BAC or CVX?
In this comparison, CVX (3.
8% yield), XOM (2. 8% yield), BAC (2. 3% yield), JPM (1. 9% yield) pay a dividend. IMSR does not pay a meaningful dividend and should not be held primarily for income.
09Is IMSR or XOM or JPM or BAC or CVX better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
37), 2. 8% yield). Terrestrial Energy Inc. (IMSR) carries a higher beta of 4. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +95. 6%, IMSR: -66. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IMSR and XOM and JPM and BAC and CVX?
These companies operate in different sectors (IMSR (Energy) and XOM (Energy) and JPM (Financial Services) and BAC (Financial Services) and CVX (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IMSR is a small-cap quality compounder stock; XOM is a large-cap quality compounder stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; CVX is a large-cap income-oriented stock. XOM, JPM, BAC, CVX pay a dividend while IMSR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.